{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:54:46Z","timestamp":1790636086574,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.03.104","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T18:00:15Z","timestamp":1460484015000},"page":"2982-2987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["MERS-CoV vaccine candidates in development: The current landscape"],"prefix":"10.1016","volume":"34","author":[{"given":"Kayvon","family":"Modjarrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.104_bib0290","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.03.104_bib0295","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.26719\/2013.19.supp1.S12","article-title":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation","volume":"19","author":"Hijawi","year":"2013","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0300","series-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Summary and Literature Update\u2013as of 11 June 2014","year":"2014"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0305","series-title":"Epidemiological Update: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","year":"2014"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2015.07.014","article-title":"Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea","volume":"38","author":"Lee","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0315","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","article-title":"A decade after SARS: strategies for controlling emerging coronaviruses","volume":"11","author":"Graham","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0320","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/v5112679","article-title":"Detection of coronaviruses in bats of various species in Italy","volume":"5","author":"Lelli","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12985-015-0289-1","article-title":"Diversity of coronavirus in bats from Eastern Thailand","volume":"12","author":"Wacharapluesadee","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0330","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid.2006.140318","article-title":"MERS-related betacoronavirus in Vespertilio superans bats, China","volume":"20","author":"Yang","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0335","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00884-14","article-title":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia","volume":"5","author":"Alagaili","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/tbed.12212","article-title":"Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005","volume":"61","author":"Alexandersen","year":"2014","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0345","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3201\/eid2008.140596","article-title":"Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992\u20132013","volume":"20","author":"Corman","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0350","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3201\/eid2007.140571","article-title":"MERS coronavirus in dromedary camel herd, Saudi Arabia","volume":"20","author":"Hemida","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0355","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to-human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0360","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coviro.2014.01.010","article-title":"MERS: emergence of a novel human coronavirus","volume":"5","author":"Raj","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0370","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1128\/JVI.02448-13","article-title":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody","volume":"87","author":"Ohnuma","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0375","first-page":"480","article-title":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014worldwide, 2012\u20132013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0380","doi-asserted-by":"crossref","first-page":"16598","DOI":"10.1073\/pnas.1310744110","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques","volume":"110","author":"de Wit","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0385","first-page":"991","article-title":"Middle East respiratory syndrome novel corona MERS-CoV infection. Epidemiology and outcome update","volume":"34","author":"Al-Tawfiq","year":"2013","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0390","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0395","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0405","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/13543776.2013.823159","article-title":"Anti-SARS coronavirus agents: a patent review (2008\u2014present)","volume":"23","author":"Kumar","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0410","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0415","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0420","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2014.02.004","article-title":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0425","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/21645515.2015.1021527","article-title":"Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus","volume":"11","author":"Tang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2014.11.013","article-title":"Receptor-binding domain-based subunit vaccines against MERS-CoV","volume":"202","author":"Zhang","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0435","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1128\/JVI.01756-13","article-title":"Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus","volume":"87","author":"Chen","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0440","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0445","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1128\/JVI.02232-14","article-title":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness","volume":"88","author":"Sui","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0450","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0455","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00650-13","article-title":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate","volume":"4","author":"Almazan","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0460","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0465","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0470","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus","volume":"145","author":"Guo","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0475","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0480","article-title":"Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly available data","volume":"6","author":"Majumder","year":"2014","journal-title":"PLoS Curr"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0485","doi-asserted-by":"crossref","first-page":"e88716","DOI":"10.1371\/journal.pone.0088716","article-title":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","volume":"9","author":"Faure","year":"2014","journal-title":"PLoS One"},{"issue":"234","key":"10.1016\/j.vaccine.2016.03.104_bib0490","doi-asserted-by":"crossref","first-page":"234ra59","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0495","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies","volume":"88","author":"Ying","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0500","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0505","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"10.1016\/j.vaccine.2016.03.104_bib0510","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0515","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3201\/eid2009.140378","article-title":"Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013","volume":"20","author":"Abroug","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0520","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/ciu359","article-title":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description","volume":"59","author":"Al-Abdallat","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0525","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cid\/ciu226","article-title":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients","volume":"59","author":"Al-Tawfiq","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of Middle East respiratory syndrome coronavirus","volume":"369","author":"Assiri","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0535","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMc1311004","article-title":"Hospital-associated Middle East respiratory syndrome coronavirus infections","volume":"369","author":"Harriman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0540","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMc1308698","article-title":"Hospital-associated Middle East respiratory syndrome coronavirus infections","volume":"369","author":"Memish","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0545","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3201\/eid2003.131159","article-title":"Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health","volume":"20","author":"Middleton","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0550","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cveq.2014.08.004","article-title":"Hendra virus","volume":"30","author":"Middleton","year":"2014","journal-title":"Vet Clin N Am Equine Pract"},{"issue":"6268","key":"10.1016\/j.vaccine.2016.03.104_bib0555","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0560","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0565","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease","volume":"89","author":"Agrawal","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.104_bib0570","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","article-title":"Animal models of Middle East respiratory syndrome coronavirus infection","volume":"122","author":"van Doremalen","year":"2015","journal-title":"Antivir Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T10:41:57Z","timestamp":1567766517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16301013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":57,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16301013"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MERS-CoV vaccine candidates in development: The current landscape","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}